0000000000038251
AUTHOR
Antonio Nuzzo
showing 2 related works from this author
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a r…
2018
Background: Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly compared the three aromatase inhibitors anastrozole, exemestane, and letrozole. We investigated the schedule and type of aromatase inhibitors to be used as adjuvant treatment for hormone receptor-positive early breast cancer. Methods: FATA-GIM3 is a multicentre, open-label, randomised, phase 3 trial of six different treatments in postmenopausal women with hormone receptor-positive early breast cancer. Eligible patients had histologically confirmed invasive hormone receptor-positive breast cancer that had been completely remov…
Emo-dramatic Robotic Stewards
2010
In this paper will be presented an heterogeneous colony of robots capable to cooperate with people as effective partners to provide different kind of support among various working environments, such as museums, offices or trade fairs. Many systems have been integrated in order to develop robots capable to assists humans during the visit of the site, to guide them and to give information about the environment. According to the drama’s theory, each robot has a different character, something like a personality, so, each of them will interact with people in a different way. Robots show also emotional, non trivial, behaviours using an LSA conceptual space capable to synthesize the different emot…